Intraoperative Imaging Device for Real-Time Identification of Critical Structures During Surgery

ChemImage Life Sciences Director Dr. Shona Stewart recently presented work surrounding critical structures identification at the 2018 Society for Optics and Photonics (SPIE) BiOS conference in San Francisco, CA. The focus of the presentation was to present results demonstrating the capabilities and performance of our proof-of-concept intraoperative MCI surgical device.

Dr. Stewart’s submitted abstract focused on the progression of ChemImage’s intraoperative device which will provide surgeons with the ability to visualize specified anatomic structures in real-time and without the use of labels (i.e. reagents).  This imaging tool employs diffuse reflectance Molecular Chemical Imaging (MCI), a technology combining molecular spectroscopy and digital imaging for non-invasive, non-contact and reagentless evaluation of human tissues.  

In order to implement real-time sensing, our team has developed a new approach to MCI, based on the principles of compressive sensing, and involving a novel, multivariate liquid crystal tunable filter technology.  This technology can facilitate real-time detection of biological materials versus complex backgrounds with equal performance to that achieved by conventional MCI instruments.

We believe that MCI has the ability to reduce surgical time, patient risk, and the need for additional surgical procedures. Learn more about our innovative intraoperative imaging endoscope.
 

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.